Author: oncologs.com

PHILADELPHIA — (June 04, 2024) — Advanced clear cell renal cell carcinoma (ccRCC) is a deadly form of kidney cancer with few treatment options; even with new immunotherapies, only around one in 10 patients ultimately survive.  Credit: The Wistar Institute PHILADELPHIA — (June 04, 2024)

TREX1 is a gene that is supposed to direct the maintenance of the entire body’s DNA, but new research shows that when people are born with mutated TREX1, it causes catastrophic damage to the DNA over time, resulting in a deadly rare disease called retinal

ABSTRACT 6006   Credit: The University of Texas MD Anderson Cancer Center ABSTRACT 6006   CHICAGO ― According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved similar clinical

OAK BROOK, Ill. – Using artificial intelligence (AI), breast radiologists in Denmark have improved breast cancer screening performance and reduced the rate of false-positive findings. Results of the study were published today in Radiology, a journal of the Radiological Society of North America (RSNA). Credit:

SAN FRANCISCO—June 4, 2024—In recent years, technologies that allow scientists to study a person’s DNA at single-molecule resolution have vastly expanded our knowledge of the human genome, the microbiome, and the genetic basis of disease. With such a detailed view of DNA, it’s possible to

LOS ANGELES – June 3, 2024 – For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers funded by a Stand Up To Cancer®

JUNE 3, 2024, NEW YORK – A novel immunotherapy approach developed by Ludwig Cancer Research scientists employs a two-pronged attack against solid tumors to boost the immune system’s ability to target and eliminate cancer cells.​​​​​​ Credit: Ludwig Cancer Research JUNE 3, 2024, NEW YORK –

MIAMI, FLORIDA (June 3, 2024) – Estelamari Rodriguez, M.D., M.P.H., is the recipient of the Patient Educator of the Year award from Cancer GRACE (Global Resource for Advancing Cancer Education). The award was presented May 31 in Chicago in recognition of Rodriguez’s work in breaking

Researchers at the RIKEN Center for Integrative Medical Sciences (IMS) have discovered numerous age-related changes in the lipid metabolism of mice, across both organs and sexes. Among these changes was the selective accumulation, throughout the body, of certain lipids produced by gut bacteria as the

BOSTON – Telemedicine visits for cancer care may not only be more convenient and easier to schedule than in-person appointments, they’re also better for the planet, new research by Dana-Farber Cancer Institute scientists shows. Credit: Dana-Farber Cancer Institute BOSTON – Telemedicine visits for cancer care